The Institute of Cancer Research
@icr.ac.uk
The ICR is making the discoveries that defeat cancer.
We're a top UK academic research centre, a postgrad college, and a charity.
📍 London (Chelsea and Sutton)
https://www.icr.ac.uk/
We're a top UK academic research centre, a postgrad college, and a charity.
📍 London (Chelsea and Sutton)
https://www.icr.ac.uk/
✨ We're delighted to welcome Dr Michelle Harrison to our Board of Trustees.
Dr Harrison brings decades of invaluable experience in global policy, public affairs, and branding. She currently serves at the President and was founding CEO of the @veriangroup.com
Dr Harrison brings decades of invaluable experience in global policy, public affairs, and branding. She currently serves at the President and was founding CEO of the @veriangroup.com
February 6, 2026 at 11:34 AM
✨ We're delighted to welcome Dr Michelle Harrison to our Board of Trustees.
Dr Harrison brings decades of invaluable experience in global policy, public affairs, and branding. She currently serves at the President and was founding CEO of the @veriangroup.com
Dr Harrison brings decades of invaluable experience in global policy, public affairs, and branding. She currently serves at the President and was founding CEO of the @veriangroup.com
🚨🎉We’re delighted to welcome the approval of the exciting plans to create a major new district for oncology and life sciences companies in Sutton, south London.
February 5, 2026 at 11:17 AM
🚨🎉We’re delighted to welcome the approval of the exciting plans to create a major new district for oncology and life sciences companies in Sutton, south London.
Today, on #WorldCancerDay, the Government have published their National Cancer Plan for England.
Read our Chief Executive, Professor @helink.bsky.social view from the ICR and find the full National Cancer plan ⤵️
www.icr.ac.uk/about-us/icr...
Read our Chief Executive, Professor @helink.bsky.social view from the ICR and find the full National Cancer plan ⤵️
www.icr.ac.uk/about-us/icr...
February 4, 2026 at 3:31 PM
Today, on #WorldCancerDay, the Government have published their National Cancer Plan for England.
Read our Chief Executive, Professor @helink.bsky.social view from the ICR and find the full National Cancer plan ⤵️
www.icr.ac.uk/about-us/icr...
Read our Chief Executive, Professor @helink.bsky.social view from the ICR and find the full National Cancer plan ⤵️
www.icr.ac.uk/about-us/icr...
Exciting news! 🚨
Along with The Royal Marsden and @imperialcollegeldn.bsky.social, we have secured major new funding through DARE UK to launch FIREDANSE – an innovative project designed to improve the safety, transparency and public confidence surrounding the use of #AI in healthcare.
🧵⤵️
Along with The Royal Marsden and @imperialcollegeldn.bsky.social, we have secured major new funding through DARE UK to launch FIREDANSE – an innovative project designed to improve the safety, transparency and public confidence surrounding the use of #AI in healthcare.
🧵⤵️
January 28, 2026 at 4:44 PM
Exciting news! 🚨
Along with The Royal Marsden and @imperialcollegeldn.bsky.social, we have secured major new funding through DARE UK to launch FIREDANSE – an innovative project designed to improve the safety, transparency and public confidence surrounding the use of #AI in healthcare.
🧵⤵️
Along with The Royal Marsden and @imperialcollegeldn.bsky.social, we have secured major new funding through DARE UK to launch FIREDANSE – an innovative project designed to improve the safety, transparency and public confidence surrounding the use of #AI in healthcare.
🧵⤵️
New research introduces the first practical guidance on how patients’ own assessments of how tolerable they find treatments (patient-reported outcomes) can be used more effectively to inform and design early-stage cancer drug trials.
A thread 🧵⬇️
A thread 🧵⬇️
January 27, 2026 at 3:28 PM
New research introduces the first practical guidance on how patients’ own assessments of how tolerable they find treatments (patient-reported outcomes) can be used more effectively to inform and design early-stage cancer drug trials.
A thread 🧵⬇️
A thread 🧵⬇️
🚨 Talazoparib has been recommended by @nicecomms.bsky.social for the treatment of advanced #ProstateCancer.
The drug now joins olaparib as one of the first genetically targeted treatments for prostate cancer. As a targeted therapy, it is a much kinder option for patients than chemotherapy.
The drug now joins olaparib as one of the first genetically targeted treatments for prostate cancer. As a targeted therapy, it is a much kinder option for patients than chemotherapy.
January 26, 2026 at 1:43 PM
🚨 Talazoparib has been recommended by @nicecomms.bsky.social for the treatment of advanced #ProstateCancer.
The drug now joins olaparib as one of the first genetically targeted treatments for prostate cancer. As a targeted therapy, it is a much kinder option for patients than chemotherapy.
The drug now joins olaparib as one of the first genetically targeted treatments for prostate cancer. As a targeted therapy, it is a much kinder option for patients than chemotherapy.
📰NEWS: A simple blood test can predict how well patients with #BreastCancer will respond to targeted therapies – before treatment begins.
Read more in our 🧵 ⤵️
Read more in our 🧵 ⤵️
January 18, 2026 at 5:24 PM
📰NEWS: A simple blood test can predict how well patients with #BreastCancer will respond to targeted therapies – before treatment begins.
Read more in our 🧵 ⤵️
Read more in our 🧵 ⤵️
🎙️ @prof-nick-james.bsky.social Nick James spoke to @lbc.co.uk following the news that NHS England will now offer abiraterone to men with high-risk non-metastatic prostate cancer.
Read the full story here ⬇️
www.icr.ac.uk/about-us/icr...
Read the full story here ⬇️
www.icr.ac.uk/about-us/icr...
January 17, 2026 at 2:21 PM
🎙️ @prof-nick-james.bsky.social Nick James spoke to @lbc.co.uk following the news that NHS England will now offer abiraterone to men with high-risk non-metastatic prostate cancer.
Read the full story here ⬇️
www.icr.ac.uk/about-us/icr...
Read the full story here ⬇️
www.icr.ac.uk/about-us/icr...
👏 We’re delighted that NHS England will now offer abiraterone to men with high-risk non-metastatic #ProstateCancer.
Discovered over 30 years ago in the labs of the ICR, abiraterone has transformed prostate cancer treatment worldwide.
Discovered over 30 years ago in the labs of the ICR, abiraterone has transformed prostate cancer treatment worldwide.
January 16, 2026 at 6:14 PM
👏 We’re delighted that NHS England will now offer abiraterone to men with high-risk non-metastatic #ProstateCancer.
Discovered over 30 years ago in the labs of the ICR, abiraterone has transformed prostate cancer treatment worldwide.
Discovered over 30 years ago in the labs of the ICR, abiraterone has transformed prostate cancer treatment worldwide.
📢 Applications are OPEN for the Emerging Clinical Academic Fellowship scheme!
Working in partnership with CRIS Cancer Foundation, we're offering two to three year fellowships designed to support the growth and development of early postdoctoral-stage clinical researchers.
Working in partnership with CRIS Cancer Foundation, we're offering two to three year fellowships designed to support the growth and development of early postdoctoral-stage clinical researchers.
January 13, 2026 at 4:34 PM
📢 Applications are OPEN for the Emerging Clinical Academic Fellowship scheme!
Working in partnership with CRIS Cancer Foundation, we're offering two to three year fellowships designed to support the growth and development of early postdoctoral-stage clinical researchers.
Working in partnership with CRIS Cancer Foundation, we're offering two to three year fellowships designed to support the growth and development of early postdoctoral-stage clinical researchers.
Giles Turner, 65, was diagnosed with aggressive prostate cancer in March 2023. Following treatment – including with the drug abiraterone, which was discovered and developed by our scientists – he is now in remission. Read Giles’ story here: www.icr.ac.uk/research-and...
January 9, 2026 at 10:01 AM
Giles Turner, 65, was diagnosed with aggressive prostate cancer in March 2023. Following treatment – including with the drug abiraterone, which was discovered and developed by our scientists – he is now in remission. Read Giles’ story here: www.icr.ac.uk/research-and...
Big news in cancer research! Our scientists have identified a key way in which our cells fix DNA during cell division, helping keep our genetic material safe and stable. The new study has revealed that a protein complex called CIP2A–TOPBP1 helps fix DNA at this critical time.
January 8, 2026 at 10:31 AM
Big news in cancer research! Our scientists have identified a key way in which our cells fix DNA during cell division, helping keep our genetic material safe and stable. The new study has revealed that a protein complex called CIP2A–TOPBP1 helps fix DNA at this critical time.
Great to see our new ICR-St Mark's 'Boomers Project' featured on BBC News!
Scientists will compare tumour samples from the 1950s–60s with today’s cancers to uncover what’s behind the rise in early‑onset bowel cancer.
Find out more 👇
www.icr.ac.uk/about-us/icr...
Scientists will compare tumour samples from the 1950s–60s with today’s cancers to uncover what’s behind the rise in early‑onset bowel cancer.
Find out more 👇
www.icr.ac.uk/about-us/icr...
January 7, 2026 at 12:09 PM
Great to see our new ICR-St Mark's 'Boomers Project' featured on BBC News!
Scientists will compare tumour samples from the 1950s–60s with today’s cancers to uncover what’s behind the rise in early‑onset bowel cancer.
Find out more 👇
www.icr.ac.uk/about-us/icr...
Scientists will compare tumour samples from the 1950s–60s with today’s cancers to uncover what’s behind the rise in early‑onset bowel cancer.
Find out more 👇
www.icr.ac.uk/about-us/icr...
Professor Paul Workman's OBE is celebrated in his local paper from back home in Cumbria ⤵️
www.newsandstar.co.uk/news/2572975...
www.newsandstar.co.uk/news/2572975...
Scientist with Cumbrian roots receives OBE in King's New Year Honours List
A SCIENTIST originally from Workington has been awarded an OBE for services to cancer research in the King’s New Year Honours List.
www.newsandstar.co.uk
December 30, 2025 at 8:43 PM
Professor Paul Workman's OBE is celebrated in his local paper from back home in Cumbria ⤵️
www.newsandstar.co.uk/news/2572975...
www.newsandstar.co.uk/news/2572975...
Professor Paul Workman, former Chief Executive of the ICR, has been awarded an OBE in the 2026 New Year Honours for his incredible impact on cancer research worldwide.
👏 Huge Congratulations, Professor Workman!
👏 Huge Congratulations, Professor Workman!
December 30, 2025 at 7:55 AM
Professor Paul Workman, former Chief Executive of the ICR, has been awarded an OBE in the 2026 New Year Honours for his incredible impact on cancer research worldwide.
👏 Huge Congratulations, Professor Workman!
👏 Huge Congratulations, Professor Workman!
🎉Season's greetings and Happy New Year from the ICR! 🎇
A huge heartfelt thank you to everyone who has supported us throughout the year.
We are so incredibly grateful ♥️
We’re closed until Monday 5 January. We have some scheduled posts going up but we won’t be closely monitoring our channels.
A huge heartfelt thank you to everyone who has supported us throughout the year.
We are so incredibly grateful ♥️
We’re closed until Monday 5 January. We have some scheduled posts going up but we won’t be closely monitoring our channels.
December 24, 2025 at 9:54 AM
🎉Season's greetings and Happy New Year from the ICR! 🎇
A huge heartfelt thank you to everyone who has supported us throughout the year.
We are so incredibly grateful ♥️
We’re closed until Monday 5 January. We have some scheduled posts going up but we won’t be closely monitoring our channels.
A huge heartfelt thank you to everyone who has supported us throughout the year.
We are so incredibly grateful ♥️
We’re closed until Monday 5 January. We have some scheduled posts going up but we won’t be closely monitoring our channels.
A recent study provides new hope for men with advanced prostate cancer. Our scientists have shown that a simple blood test could help doctors predict whether chemotherapy will work for certain patients or just cause unnecessary side effects.
www.icr.ac.uk/about-us/icr...
🧵Read our thread below ⬇️
www.icr.ac.uk/about-us/icr...
🧵Read our thread below ⬇️
Blood test could spare men with advanced prostate cancer from futile chemotherapy
Blood test could spare men with advanced prostate cancer from futile chemotherapy
www.icr.ac.uk
December 22, 2025 at 11:35 AM
A recent study provides new hope for men with advanced prostate cancer. Our scientists have shown that a simple blood test could help doctors predict whether chemotherapy will work for certain patients or just cause unnecessary side effects.
www.icr.ac.uk/about-us/icr...
🧵Read our thread below ⬇️
www.icr.ac.uk/about-us/icr...
🧵Read our thread below ⬇️
🧠Progress to improve brain tumour treatment is urgently needed.
We're proud to be contributing to a new @nihr.bsky.social Brain Tumour Research Consortium, led by Prof Juanita Lopez, who's based in our Joint Drug Development Unit with The Royal Marsden.
Read more ⤵️
www.icr.ac.uk/about-us/icr...
We're proud to be contributing to a new @nihr.bsky.social Brain Tumour Research Consortium, led by Prof Juanita Lopez, who's based in our Joint Drug Development Unit with The Royal Marsden.
Read more ⤵️
www.icr.ac.uk/about-us/icr...
ICR researchers to contribute to £13.7m brain tumour research consortium
ICR researchers to contribute to £13.7m brain tumour research consortium
www.icr.ac.uk
December 19, 2025 at 12:14 PM
🧠Progress to improve brain tumour treatment is urgently needed.
We're proud to be contributing to a new @nihr.bsky.social Brain Tumour Research Consortium, led by Prof Juanita Lopez, who's based in our Joint Drug Development Unit with The Royal Marsden.
Read more ⤵️
www.icr.ac.uk/about-us/icr...
We're proud to be contributing to a new @nihr.bsky.social Brain Tumour Research Consortium, led by Prof Juanita Lopez, who's based in our Joint Drug Development Unit with The Royal Marsden.
Read more ⤵️
www.icr.ac.uk/about-us/icr...
If you are a clinical professional looking to understand more about image-guided and adaptive radiotherapy techniques, sign up for our 2-day course today. The closing date to register is Monday 12 January 2026.
Find out more ➡️ www.icr.ac.uk/study-and-ca...
Find out more ➡️ www.icr.ac.uk/study-and-ca...
December 19, 2025 at 10:29 AM
If you are a clinical professional looking to understand more about image-guided and adaptive radiotherapy techniques, sign up for our 2-day course today. The closing date to register is Monday 12 January 2026.
Find out more ➡️ www.icr.ac.uk/study-and-ca...
Find out more ➡️ www.icr.ac.uk/study-and-ca...
Reposted by The Institute of Cancer Research
An early Christmas present! The ICR’s new Hydra Bio FIB-SEM has been delivered, which will sit at the heart of a consortium between the @icr.ac.uk, Imperial, QMUL and KCL. Currently being stored at Imperial, it’ll be installed in a brand new lab at the ICR next year. Exciting things coming in 2026!🔬
December 17, 2025 at 12:58 PM
An early Christmas present! The ICR’s new Hydra Bio FIB-SEM has been delivered, which will sit at the heart of a consortium between the @icr.ac.uk, Imperial, QMUL and KCL. Currently being stored at Imperial, it’ll be installed in a brand new lab at the ICR next year. Exciting things coming in 2026!🔬
A recent study has revealed why some #myeloma drugs stop working – and why newer ones can still succeed.
🧵 Read our thread to find out more ⤵️
🧵 Read our thread to find out more ⤵️
December 17, 2025 at 8:04 AM
A recent study has revealed why some #myeloma drugs stop working – and why newer ones can still succeed.
🧵 Read our thread to find out more ⤵️
🧵 Read our thread to find out more ⤵️
Would you like to be involved in a video about radiotherapy trials?
We're creating a series videos with @cancerresearchuk.org and @ucl.ac.uk Cancer Trials Centre for people who are considering taking part in a research study or who want to learn more about research.
www.icr.ac.uk/research-and...
We're creating a series videos with @cancerresearchuk.org and @ucl.ac.uk Cancer Trials Centre for people who are considering taking part in a research study or who want to learn more about research.
www.icr.ac.uk/research-and...
December 15, 2025 at 2:28 PM
Would you like to be involved in a video about radiotherapy trials?
We're creating a series videos with @cancerresearchuk.org and @ucl.ac.uk Cancer Trials Centre for people who are considering taking part in a research study or who want to learn more about research.
www.icr.ac.uk/research-and...
We're creating a series videos with @cancerresearchuk.org and @ucl.ac.uk Cancer Trials Centre for people who are considering taking part in a research study or who want to learn more about research.
www.icr.ac.uk/research-and...
Huge congratulations to Amanda and Ray Mifsud, founders of Abbie's Army, who were awarded an MBE by HRH The Princess Royal at St James’s Palace last week.
We are so grateful for all your support for our childhood brain tumour research. 💛
www.independent.co.uk/news/uk/home...
We are so grateful for all your support for our childhood brain tumour research. 💛
www.independent.co.uk/news/uk/home...
Cancer charity leaders and Royal Navy officer honoured at ‘extraordinary’ palace
An investiture ceremony was held at St James’s Palace for the first time in four years on Thursday.
www.independent.co.uk
December 9, 2025 at 6:36 AM
Huge congratulations to Amanda and Ray Mifsud, founders of Abbie's Army, who were awarded an MBE by HRH The Princess Royal at St James’s Palace last week.
We are so grateful for all your support for our childhood brain tumour research. 💛
www.independent.co.uk/news/uk/home...
We are so grateful for all your support for our childhood brain tumour research. 💛
www.independent.co.uk/news/uk/home...
🚨 The South London Paediatric Neuro-Oncology Network — featuring the ICR has been designated a @tessajowellbcm.bsky.social Centre of Excellence for Children 💫
This means better care, stronger collaboration, and more hope for children with brain tumours.
This means better care, stronger collaboration, and more hope for children with brain tumours.
December 2, 2025 at 9:35 AM
🚨 The South London Paediatric Neuro-Oncology Network — featuring the ICR has been designated a @tessajowellbcm.bsky.social Centre of Excellence for Children 💫
This means better care, stronger collaboration, and more hope for children with brain tumours.
This means better care, stronger collaboration, and more hope for children with brain tumours.